Research ArticleCANCER IMMUNOLOGY

Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer

See allHide authors and affiliations

Science Immunology  31 Jan 2020:
Vol. 5, Issue 43, eaav3937
DOI: 10.1126/sciimmunol.aav3937

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Immunology